Zhi Hong Chen
Direttore/Membro del Consiglio presso Shanghai Neutan Pharmaceutical Co., Ltd.
Profilo
Attualmente, Zhi Hong Chen è direttore generale e direttore di Zhejiang Jiuzhou Pharmaceutical Co.
Posizioni attive di Zhi Hong Chen
| Società | Posizione | Inizio |
|---|---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
 Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Zhi Hong Chen
| Società | Posizione | Fine |
|---|---|---|
| ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Health Technology |
| Aziende private | 1 |
|---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Health Technology |
- Borsa valori
- Insiders
- Zhi Hong Chen
